Figure 1From: Increased plasma apoM levels in the patients suffered from hepatocellular carcinoma and other chronic liver diseasesComparisons of plasma apoM levels in HCC patients, chronic hepatitis, liver cirrhosis and in controls. Plasma apoM levels were determined by dot blotting analysis. Data are represented as means ± SE and it expressed as the intensity/mm2 that was analyzed by the software of Quantity One. * < 0.05; ** < 0.01 vs. controls.Back to article page